Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market

Introduction: After the marketing approval of a medicine, pharmacovigilance monitoring must be carried out at an international level and the necessary measures must be adopted to reduce the risk that its use may present. Restrictive measures are not taken with the same speed in all countries and the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caffaratti, Mariana, Cañás, Martín, Domosbian, Daniel Eduardo, Giraudo, Emiliano, González, Ana María, Lorenzo, Andrea, Núñez Montoya, Susana Núñez, Rocha, María Teresa, Traverso, María Luz, Uema, Sonia
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2025
Materias:
safety-based drug withdrawals
pharmacovigilance
drug-related side effects and adverse reactions
product surveillance
postmarketing
retirada de medicamento por seguridad
farmacovigilancia
efectos colaterales y reacciones adversas relacionados con medicamentos
vigilancia de productos comercializados
retirada de medicamento baseada em segurança
farmacovigilância
efeitos colaterais e reações adversas relacionados a medicamentos
vigilância de produtos comercializados
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/46049
Aporte de:
Revista de la Facultad de Ciencias Médicas de Córdoba de Universidad Nacional de Córdoba

Ejemplares similares

Ejemplares similares